Zepp Health (ZEPP) has released an update.
Zepp Health Corporation disclosed a Q1 2024 revenue of $39.8 million, alongside a record-high gross margin and a net loss per share of $0.06, with a stronger focus on its self-branded products that now constitute over 85% of total revenues. The company’s strategic product diversification, including the launch of new product lines like the Helio Ring and Amazfit Bip 5 Unity, aims to boost market share and user engagement. Despite a seasonal decline in revenue compared to the previous year, the company maintains a positive operating cash flow and a strong cash reserve, indicating a firm commitment to strategic investments and innovation for future growth.
For further insights into ZEPP stock, check out TipRanks’ Stock Analysis page.
